Letter to the editorHepatitis C liver disease during COVID-19 pandemic in Egypt: Challenges and way forward
Section snippets
Human and animal rights
The authors declare that the work described has not involved experimentation on humans or animals.
Informed consent and patient details
The authors declare that the work described does not involve patients or volunteers.
Disclosure of interest
The authors declare that they have no competing interest.
Funding
This work did not receive any grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author contributions
All authors have contributed, read and approved the final manuscript.
References (12)
- et al.
COVID-19 in Egypt: through crisis to adaptation; a gastroenterologist's perspective
Arab J Gastroenterol
(2020) - et al.
Impact of the COVID-19 pandemic on HCV elimination in Spain
J Hepatol
(2021) - et al.
Impact of COVID-19 on global HCV elimination efforts
J Hepatol
(2021) - et al.
Hepatitis C in Egypt – past, present, and future
Int J Gen Med
(2017) - et al.
Accelerating hepatitis C virus elimination in Egypt by 2030: a national survey of communication for behavioral development as a modelling study
PLoS One
(2021) - et al.
Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations
World J Gastroenterol
(2018)
There are more references available in the full text version of this article.
Cited by (0)
© 2021 Elsevier Masson SAS. All rights reserved.